Meet PSI at Clinical Outsourcing Group: Small and Mid Biopharma Summit!
PSI CRO is attending COG: Small and Mid Biopharma Summit to meet with emerging and mid-size sponsors navigating operational complexity, investor pressure, and the need for predictable clinical execution.
The Bay Area continues to shape how sponsors approach clinical operations, AI adoption, outsourcing strategy, and enrollment planning. PSI, a contract research organization founded in 1995 and operating across 58 countries, will be onsite to discuss how sponsors can maintain operational control while scaling global phase 2–3 programs.
Sponsors attending the meeting can connect with PSI on topics including strategic outsourcing models, enrollment predictability, AI-enabled feasibility, and site activation performance. PSI delivers 95% FPI on time and 97% LPI on time across global studies, helping sponsors reduce execution risk while maintaining timeline confidence.
Attending team members:
-
Alex Goñi
Senior Director, Business Development - Yeonjoo Kang
Senior Director, Business Development
Related resources:
Blog: The site economy: Understanding site decision-making
Webinar: Agentic AI in Clinical Trials — Swiss Biotech Day Panel
White Paper: The operational reality of agentic AI in phase 2-3 trials
